RDGT Ridgetech Inc. Annual reports only
Retail-Drug Stores and Proprietary Stores · Nasdaq · SEC CIK 1856084 · Fiscal year ends 03/31
Financial factors as of 2026-03-31 (FY2026), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY10.2%
TTM net income YoY-112.3%
TTM EPS YoY-106.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—
Margins
Gross margin3.6%
Operating margin-1.4%
Net margin-0.9%
FCF margin-1.1%
EBITDA margin-1.1%
Returns
ROE-3.6%
ROA-1.9%
ROIC (approx.)-7.4%
Asset turnover1.98x
Leverage & solvency
Liabilities / assets40.9%
Debt / equity0.00x
Current ratio2.31x
Interest coverage-27.82x
Cash quality & payout
Operating cash flow / net income1.11x
Accruals ratio0.2%
Payout ratio—
Capex / revenue0.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $132.16M | $119.97M |
| Cost of revenue | $127.41M | $116.13M |
| Gross profit | $4.75M | $3.84M |
| SG&A expense | $3.58M | $3.34M |
| Operating income | -$1.87M | -$1.04M |
| Interest expense | $67,069 | -$92,834 |
| Pretax income | -$1.35M | -$950,660 |
| Income tax | -$99,098 | $503,524 |
| Net income | -$1.25M | $10.19M |
| EBITDA | -$1.50M | $101,901 |
| EPS (basic) | -17.21 | 275.87 |
| EPS (diluted) | -17.21 | 275.87 |
| Weighted avg. shares (diluted) | 72,668 | 36,954 |
| Balance sheet | ||
| Cash & equivalents | $17.91M | $12.78M |
| Receivables | $32.47M | $27.81M |
| Inventory | $8.26M | $9.76M |
| Current assets | $64.56M | $59.71M |
| PP&E, net | $5,723 | $8,931 |
| Goodwill | $1.46M | $1.46M |
| Intangibles | $3.00M | $3.30M |
| Total assets | $69.03M | $64.48M |
| Current liabilities | $27.89M | $34.36M |
| Total liabilities | $28.25M | $34.85M |
| Shareholders' equity | $40.78M | $29.64M |
| Shares outstanding | 887,271 | 39,033 |
| Cash flow statement | ||
| Operating cash flow | -$1.39M | $1.25M |
| Capital expenditure | $449 | $155,360 |
| Free cash flow | -$1.39M | $1.09M |
| Investing cash flow | -$449 | -$18.14M |
| Financing cash flow | -$29,714 | $1.51M |
| Depreciation & amortization | $363,686 | $1.14M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.